Q

Qiagen NV
D

QGEN

51.800
USD
0.54
(1.05%)
مغلق
حجم التداول
65,865
الربح لكل سهم
2
العائد الربحي
0.48
P/E
120
حجم السوق
11,217,614,734
أصول ذات صلة
NEOUSD
NEOUSD
0.03017
(0.45%)
6.59608 USD
BDX
BDX
1.850
(1.01%)
185.410 USD
C
CRL
-0.340
(-0.19%)
176.950 USD
DGX
DGX
-3.520
(-2.05%)
168.460 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
HOLX
HOLX
0.370
(0.56%)
66.500 USD
IQV
IQV
-1.690
(-0.84%)
199.180 USD
LH
LH
-2.48
(-0.93%)
264.80 USD
N
NEO
-0.12500
(-1.95%)
6.29000 USD
TMO
TMO
3.25
(0.68%)
478.43 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).